Navigation Links
Onyx Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference

EMERYVILLE, Calif., March 11, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Barclays Capital 2011 Global Healthcare Conference on Thursday, March 17, 2011 at 10:15 a.m. Eastern Time (7:15 a.m. Pacific Time).  

Interested parties may access a live webcast of the presentation on our website at:

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software.  For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through March 31, 2011.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals Inc., is developing and marketing Nexavar® (sorafenib) tablets, a small molecule drug that is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. Beyond Nexavar, Onyx has established a development pipeline of anticancer compounds at various stages of clinical testing, including carfilzomib, a selective proteasome inhibitor, that is currently being evaluated in multiple clinical trials for the treatment of patients with relapsed or relapsed/refractory multiple myeloma and solid tumors. ONX 0801, an alpha-folate receptor targeted inhibitor of thymidylate synthase, and ONX 0912, an oral proteasome inhibitor, are currently in Phase 1 testing. For more information about Onyx, visit the company's website at

Nexavar® (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals.

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named Woman of the Year by Arthritis Foundation
2. Conatus Pharmaceuticals Will Display HCV Clinical Trial Data at the International Liver Congress™ (EASL) in March
3. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
4. Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
5. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
6. Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
7. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
8. Isis Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
9. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
10. Questcor Pharmaceuticals to Present at the Barclays Capital Global Healthcare Conference
11. Jazz Pharmaceuticals to Present at Upcoming Investor Conferences
Post Your Comments:
(Date:10/13/2015)... , Oct. 13, 2015 China Jo-Jo ... " China Jo-Jo "), a leading China-based retail, wholesale ... through its own online and retail pharmacies, announced preliminary ... official branded online pharmacy through , growing ... a record 25%. China Jo-Jo,s ...
(Date:10/13/2015)... Oct. 13, 2015  Asterias Biotherapeutics, Inc. (NYSE ... UK-based Cell Therapy Catapult to advance development of ... dendritic cell immunotherapy. Under the agreement, the Cell ... for AST-VAC2 to support advanced clinical trials and ... --> The Cell Therapy Catapult ...
(Date:10/12/2015)...  Former White House Spokesman, and Drug Czar Public Affair ... Committee, Robert Weiner , and Policy Analyst Daniel ... that this is now a potential bipartisan campaign and debate ... , Carly Fiorina to Rand Paul ... which they call "a shocker: 23 million need but do ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... Scientists in Seattle and Vancouver compared the ... with or without mesothelioma. Surviving Mesothelioma has just posted an article on the new ... Laboratories in Seattle and the University of British Columbia found that certain genetic alterations ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... establishment of telemedicine programs in communities throughout Georgia, along with affiliate organizations, Alabama ... schedule for their regional telehealth summits for Fall 2015. , Each of ...
(Date:10/13/2015)... ... 13, 2015 , ... California Southern University has named Dr. ... her Doctor of Nursing Practice from the renowned Johns Hopkins University—comes to CalSouthern ... Dr. McLeod’s long and successful nursing practice included a variety of patient care, ...
(Date:10/13/2015)... ... October 13, 2015 , ... Local Gold’s Gym franchise owner, ... Conference on August 26. Berry, who owns and operates Gold's Gym Cheyenne ... growing Gold’s Gyms in the United States. A brand leader in global fitness, Gold’s ...
(Date:10/13/2015)... ... October 13, 2015 , ... Breathing is ... do not breathe correctly. According to T’ai Chi (also spelled “Taiji”) and Qigong ... breathe correctly, in concert with the 7,000 year old tradition they teach, can ...
Breaking Medicine News(10 mins):